ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PYC Physiomics Plc

1.50
0.00 (0.00%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Physiomics Plc LSE:PYC London Ordinary Share GB00BDR6W943 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.50 1.40 1.60 1.50 1.50 1.50 33,133 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 597k -477k -0.0035 -4.29 2.03M
Physiomics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker PYC. The last closing price for Physiomics was 1.50p. Over the last year, Physiomics shares have traded in a share price range of 0.925p to 3.15p.

Physiomics currently has 135,472,478 shares in issue. The market capitalisation of Physiomics is £2.03 million. Physiomics has a price to earnings ratio (PE ratio) of -4.29.

Physiomics Share Discussion Threads

Showing 20501 to 20517 of 30125 messages
Chat Pages: Latest  821  820  819  818  817  816  815  814  813  812  811  810  Older
DateSubjectAuthorDiscuss
27/2/2018
19:55
PW, that could have gone either way as we both know - I threw it out their as I had to disappear for a while but clearly 'lost' on this occasion ;o).
wossupsa
27/2/2018
17:43
Pwhite?????
spacedust
27/2/2018
17:31
We are wakners
spacedust
27/2/2018
16:48
wossupusa - 12:00 - "PW HEMO to go blue and another 30% up before close? "You were saying . Do not try and take me on.!
pwhite73
27/2/2018
13:26
Rns released by Sar. Jeez what an rns. Pwhite any thoughts on Sar RNS?

I don't think market has caught the news.

spacedust
27/2/2018
12:24
courtesy of stiggy


three major contracts in JUST three months! Hello!!!!

Dr Jim Millen, CEO said: "We believe that the signing of agreements with three major pharmaceutical clients within the space of three months is a real sign of the confidence in our technology that is starting to build within the industry. Our aim now will be to develop longer-term relationships with these major companies and to secure further pre-clinical and clinical projects."



So they've got their foot in the door with 3 Major Pharmas out of a client list of 58

And they've only just started rolling it out within those clients

Merck went from £30k deals to €500k deals

Why shouldn't Glaxo or whoever else also go from £30-70k initial deals to £500+k ?

I think recent Industry and Regulatory approvals and validation of In Silico Clinical Trials (aka Biosimulation aka 'Modelling and Simulation') is causing a domino effect and Physiomics are going to be HUGE beneficiaries of this perfect storm.

the patient investor
27/2/2018
12:22
If I was any calmer people would be checking if I had a pulse.
wossupsa
27/2/2018
12:11
Outlook

We are looking forward to a STRONG (my capitals) second half as a result of the Merck KGaA deal announced in November 2017 and the new contracts with major pharmaceutical clients announced in January and February.


Honestly guys, what do you want more? a cheap stock with a great future

no brainer

the patient investor
27/2/2018
12:08
The Company now has clients in Europe and North America and is working on a range of projects including in immuno-oncology applications. For the first time in recent years the Company is seeking to expand the size of its technical team to increase its capacity to service new clients.


i will repeat for the thickkos

INCREASE ITS CAPACITY TO SERVICE NEW NEW NEW NEW CLIENTS!


hello!!

the patient investor
27/2/2018
12:01
PW, HEMO to go blue and add another 30% before close?
wossupsa
27/2/2018
11:58
so, why merck paid us half a million?
the patient investor
27/2/2018
11:57
The Company now has clients in Europe and North America and is working on a range of projects including in immuno-oncology applications. For the first time in recent years the Company is seeking to expand the size of its technical team to increase its capacity to service new clients.
the patient investor
27/2/2018
11:56
Yes but you don't have any technology to sell. As per my previous posts you are using your technology to carry out research work. To sell it you require exclusive patents. I have been over this ground.
pwhite73
27/2/2018
11:51
I'd add that the speed with which new companies will buy our technology will increase exponentially, they called it the halo effect, we are not anymore a newbie trying to prove something.

as said we have received the seal of approval from a giant drug firm and this is the best possible advert for future contracts.

space, just be patient, it must hurt horribly, but please don't give up hope on your 60p stake

the patient investor
27/2/2018
11:47
my point is that pharmas spend HUGE money and HUGE amount of time to develop a new drug. With this technology they will drastically reduce both those parameters and be able to take their drugs to the market sooner and more cost effectively.

This product in my opinion must be of huge appeal to ALL drug companies, so our potential market is enormous.

the patient investor
27/2/2018
11:42
Those who sold in the teens have made money. Those who didn't like me who did read the rns are nursing loses. What is your point?
spacedust
27/2/2018
11:39
Last time I came across you tpi you were selling due to a lack of patience funnily enough.
wossupsa
Chat Pages: Latest  821  820  819  818  817  816  815  814  813  812  811  810  Older

Your Recent History

Delayed Upgrade Clock